EUNETWORKS
7.12.2023 09:01:28 CET | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, was recently featured in an interview series with leaders from across industries undertaken during the United Nations Climate Conference (COP28) in Dubai. The series of interviews captures lessons learned, sustainability success stories and key messages for the future from leaders across the energy, technology and telecom, manufacturing and finance industries. euNetworks has also released its latest Sustainability Report, detailing the company’s commitment to sustainability and substantial progress over the last year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207410743/en/
Paula Cogan, CEO of euNetworks (Photo: Business Wire)
euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 17 cities and also operates a highly differentiated long haul network that spans 66,000 kilometres across 17 countries today. As a specialist in the sector, euNetworks continues to grow and invest in partnership with its customers, investing in new technologies and deepening its unique fibre network in Europe. The company is undertaking this growth with a strong focus on sustainability and has been working hard through 2023 to deliver tangible progress on its long-term sustainability goals.
“Throughout euNetworks’ history, we have remained dedicated to our core values, and our commitment to sustainability has never been stronger,” said Paula Cogan, Chief Executive Officer of euNetworks. “We understand the impact our operations can have on the environment, and we are committed to reducing our carbon footprint and contributing to global efforts in combatting climate change and transitioning to a low-carbon economy.”
COP28 has a focus on four paradigm shifts – fast-tracking the energy transition and slashing emissions before 2030; transforming climate finance by delivering on old promises and setting the framework for a new deal on finance; putting nature, people, lives, and livelihoods at the heart of climate action; and mobilising for the most inclusive COP ever. euNetworks’ efforts align with those shifts.
“Our pledge to be net-zero carbon by 2040 is not just an aspiration but a driving force behind our actions,” said Cogan. “We have joined the Climate Pledge, demonstrating our unwavering commitment to combat climate change. Setting 1.5°C-aligned science-based targets across Scopes 1, 2, and 3 is a testament to euNetworks’ ambition to be leaders in environmental responsibility in the digital infrastructure ecosystem. We shifted to renewable energy sources across our business, and we’ve reached our target of 98.8% today. We obtained a Sustainability Linked Loan in 2021 that enabled us to embed our commitment to sustainability by including ESG-linked KPIs into our financial framework. We are dedicated to pioneering innovation in carbon measurement tools for service and project-based emissions, empowering our customers to measure and address Scope 3 emissions with precision, and helping suppliers to reduce their carbon footprint. Our award-winning carbon tools are actively used in our operations and by our customers today. We aim to deliver the lowest carbon footprint per bit of data transmitted, which we take seriously and drives our daily efforts.”
euNetworks’ sustainability strategy, outlined in the company’s latest Sustainability Report, encompasses long-term objectives, focusing on carbon neutrality, a diverse, equitable, and inclusive workforce, responsible supply chain management, customer-driven innovation, and biodiversity conservation:
- Net Zero: We have set our sights on achieving net-zero carbon emissions by 2040. This ambitious target involves increasing our use of renewable energy sources, implementing innovative technologies, and adopting efficient operational practices to minimise environmental impact.
- Diverse, Equitable, and Inclusive workforce: We champion an inclusive culture that values the richness of our employees' backgrounds and perspectives. We prioritise building a diverse, equitable and inclusive culture, and our goal is to achieve gender balance in our workforce, positioning us as a preferred employer within the telecoms industry.
- Responsible Supply Chain Management: We collaborate with our partners to establish responsible supply chain practices. This involves promoting transparency, ethical sourcing, and reducing our environmental footprint.
- Customer-Focused Innovation: We are committed to ongoing innovation, developing bandwidth infrastructure solutions prioritising energy efficiency, emissions reduction, and circular economy principles.
- Biodiversity Preservation: Our dedication extends to contributing to biodiversity conservation and ecosystem resilience. Our initiatives promote biodiversity awareness, protect natural habitats and support reforestation efforts.
“It’s clear that while euNetworks has made great progress towards its sustainability goals, we are still at the beginning of our journey,” said Cogan. “Collaboration among suppliers, customers, partners and the broader ecosystem will be essential to achieving substantial, long-term environmental change. In an industry fundamental to economies and society, euNetworks is committed to making significant sustainability strides of its own and supporting the bigger picture of businesses working together to solve the immense challenges of sustainability and climate change.”
To read euNetworks’ full Sustainability Report, go to https://eun.io/sustainability
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre-based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 518 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231207410743/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
